Search Results

There are 27046 results for: content related to: The tyranny of the majority and the interchangeability of drugs

  1. A Randomized Study of the Effects of Food on the Pharmacokinetics of Once-Daily Extended-Release Hydromorphone in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 11, November 2011, Pages: 1571–1579, Mr Kenneth Todd Moore, Ms Dominique St-Fleur, Ms Nadia Cardillo Marricco, Mr Jay Ariyawansa, Ms Véronique Pagé, Dr Jayalakshmi Natarajan, Dr Gaetano Morelli and Dr Ute Richarz

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010383858

  2. You have free access to this content
    The efficacy of a 40-mg extended-release formulation of cisapride in the treatment of patients with gastro-oesophageal reflux

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 1, January 2000, Pages: 113–122, Katschinski, Schirra and Arnold

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00672.x

  3. Disulfiram-loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 2, February 2015, Pages: 189–198, Clara S. Baffoe, Nhi Nguyen, Peter Boyd, Weiguang Wang, Mark Morris and Christopher McConville

    Version of Record online : 10 DEC 2014, DOI: 10.1111/jphp.12330

  4. You have free access to this content
    Are immediate- and extended-release drugs interchangeable?

    Acta Psychiatrica Scandinavica

    Volume 127, Issue 1, January 2013, Pages: 78–80, Dan Cohen and Anton J. M. Loonen

    Version of Record online : 2 NOV 2012, DOI: 10.1111/acps.12015

  5. You have free access to this content
    Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

    Intervention Review

    The Cochrane Library

    Ole Jakob Storebø, Erica Ramstad, Helle B. Krogh, Trine Danvad Nilausen, Maria Skoog, Mathilde Holmskov, Susanne Rosendal, Camilla Groth, Frederik L Magnusson, Carlos R Moreira-Maia, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Bente Forsbøl, Erik Simonsen and Christian Gluud

    Published Online : 25 NOV 2015, DOI: 10.1002/14651858.CD009885.pub2

  6. Extended-Release Formulations of Antiepileptic Drugs: Rationale and Comparative Value

    Epilepsy Currents

    Volume 9, Issue 6, November/December 2009, Pages: 153–157, Emilio Perucca

    Version of Record online : 16 OCT 2009, DOI: 10.1111/j.1535-7511.2009.01326.x

  7. Which anticholinergic drug for overactive bladder symptoms in adults

    Intervention Review

    The Cochrane Library

    Priya Madhuvrata, June D Cody, Gaye Ellis, G Peter Herbison and E. Jean C Hay-Smith

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD005429.pub2

  8. Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of Extended-Release Formulations of Oxybutynin and Tolterodine

    The Journal of Clinical Pharmacology

    Volume 45, Issue 8, August 2005, Pages: 961–968, Roger Dmochowski, Andrew Chen, Gayatri Sathyan, Scott MacDiarmid, Shalini Gidwani and Suneel Gupta

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005278055

  9. Prescription Histories and Dose Strengths Associated with Overdose Deaths

    Pain Medicine

    Volume 15, Issue 7, July 2014, Pages: 1187–1195, Anne Hirsch, Scott K. Proescholdbell, William Bronson and Nabarun Dasgupta

    Version of Record online : 15 FEB 2014, DOI: 10.1111/pme.12391

  10. Sleeping through the night: Are extended-release formulations the answer?

    Journal of the American Academy of Nurse Practitioners

    Volume 20, Issue 2, February 2008, Pages: 69–75, Christina Calamaro

    Version of Record online : 7 FEB 2008, DOI: 10.1111/j.1745-7599.2007.00279.x

  11. Historical Review of Carbamazepine for the Treatment of Bipolar Disorder

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 1, January 2007, Pages: 68–88, Steven C. Stoner, Leigh Anne Nelson, Jessica W. Lea, Patricia A. Marken, Roger W. Sommi and Megan M. Dahmen

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.1.68

  12. Pharmacoeconomic Evaluation of Antimuscarinic Agents for the Treatment of Overactive Bladder

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 12, December 2006, Pages: 1694–1702, Yu Ko, Daniel C. Malone and Edward P. Armstrong

    Version of Record online : 11 JAN 2012, DOI: 10.1592/phco.26.12.1694

  13. You have free access to this content
    Pharmacokinetic Evaluation of Twice-Daily Extended-Release Carbamazepine (CBZ) and Four-Times-Daily Immediate-Release CBZ in Patients with Epilepsy


    Volume 39, Issue 3, March 1998, Pages: 274–279, William R. Garnett, Benjamin Levy, Angus M. McLean, Yuxin Zhang, Richard A. Couch, Edward M. Rudnic, John M. Pellock and George W. Belendiuk

    Version of Record online : 3 AUG 2005, DOI: 10.1111/j.1528-1157.1998.tb01372.x

  14. Oral Extended-Release Formulations

    Pharmaceutical Manufacturing Handbook: Production and Processes

    Anette Larsson, Susanna Abrahmsén-Alami, Anne Juppo, Pages: 1191–1222, 2007

    Published Online : 28 AUG 2007, DOI: 10.1002/9780470259818.ch30

  15. Pharmacokinetics of Gabapentin in a Novel Gastric-Retentive Extended-Release Formulation: Comparison With an Immediate-Release Formulation and Effect of Dose Escalation and Food

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 346–358, Cuiping Chen, Verne E. Cowles and Eddie Hou

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010368411

  16. Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV-1 attachment inhibitor phosphate ester prodrug

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 6, June 2013, Pages: 1742–1751, Jonathan Brown, Caly Chien, Peter Timmins, Andrew Dennis, Walter Doll, Erik Sandefer, Richard Page, Richard E. Nettles, Li Zhu and Dennis Grasela

    Version of Record online : 5 APR 2013, DOI: 10.1002/jps.23476

  17. Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic-Controlled Extended-Release Methylphenidate Formulation in Humans

    The Journal of Clinical Pharmacology

    Volume 47, Issue 12, December 2007, Pages: 1476–1488, Dr Doll A. Parasrampuria, Dr Kerr A. Schoedel, Dr Reinhard Schuller, Ms Joan Gu, Dr Patrick Ciccone, Dr Steve A. Silber and Dr Edwar M. Sellers

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007308615

  18. Terminology challenges: Defining modified release dosage forms in veterinary medicine

    Journal of Pharmaceutical Sciences

    Volume 99, Issue 8, August 2010, Pages: 3281–3290, Marilyn N. Martinez, Danielle Lindquist and Sanja Modric

    Version of Record online : 8 MAR 2010, DOI: 10.1002/jps.22095

  19. Development of oral extended release formulations of 6-hydroxybuspirone

    Biopharmaceutics & Drug Disposition

    Volume 33, Issue 9, December 2012, Pages: 522–535, Sarah J. Nicholson, Peter Timmins, Randy C. Dockens, Alyson Connor, Robert Croop, Peter Ferrie, Jianing Zeng, Andrew B. Dennis and Ian Wilding

    Version of Record online : 12 NOV 2012, DOI: 10.1002/bdd.1819

  20. Bioavailability and In-vitro/in-vivo Correlation for Propranolol Hydrochloride Extended-release Bead Products Prepared Using Aqueous Polymeric Dispersions

    Journal of Pharmacy and Pharmacology

    Volume 48, Issue 12, December 1996, Pages: 1276–1284, Gurvinder Singh Rekhi and Sunil S. Jambhekar

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1996.tb03936.x